A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

NIH Scientists Test in an Animal Model a Surgical Technique to Improve Cell Therapy for Dry Age-Related Macular Degeneration ...

Cancer patients living in southern Utah and nearby states now have a facility offering a highly specialized treatment much closer to home.

G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has ...

Stem cells from donated placentas appear safe and may help ease secondary progressive MS, a small open-label Phase 1 clinical ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Elevated LDH and higher international prognostic index were also predictors of poor outcomes on bispecific antibodies, ...